市場調査レポート
商品コード
1379192
整形外科用バイオマテリアル市場:材料タイプ別、用途別、地域別、2023-2028年Orthopedic Biomaterials Market Report by Material Type, Application, and Region 2023-2028 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
整形外科用バイオマテリアル市場:材料タイプ別、用途別、地域別、2023-2028年 |
出版日: 2023年11月02日
発行: IMARC
ページ情報: 英文 141 Pages
納期: 2~3営業日
|
整形外科用バイオマテリアルの世界市場規模は、2022年に163億米ドルに達しました。今後、IMARC Groupは、同市場が2028年までに297億米ドルに達し、2022~2028年の成長率(CAGR)は10.5%に達すると予測しています。老人人口の増加、急速な製品革新、ヘルスケア産業の著しい成長、さまざまな政府イニシアチブの実施、広範な研究開発(R&D)活動などが市場を牽引する主な要因です。
整形外科用バイオマテリアルは、整形外科手術において、損傷した骨や関節組織を置換または修復するために使用される物質です。これらは合成または天然のもので、骨や関節組織の特性を模倣するように設計されています。セラミックや生体活性ガラス、ポリマー、リン酸カルシウムセメント、金属、複合材料などが一般的な材料の種類です。整形外科用バイオマテリアルは、人工股関節、人工膝関節、人工肩関節などの関節置換術、骨折固定、脊椎インプラント、骨移植、軟組織修復などに広く使用されています。これらは高い強度、延性、破壊靭性、硬度、耐食性、成形性、生体適合性を示します。
変形性関節症、骨粗しょう症、骨折など、さまざまな筋骨格系障害のリスクを抱えやすい老年人口が世界中で増加していることは、市場成長を促進する主要因の1つです。これに伴い、スポーツ外傷、退行性関節疾患、外傷性骨折などの整形外科疾患や傷害の有病率の増加が市場成長を後押ししています。さらに、整形外科疾患に対する意識の高まりと高度な治療ソリューションの利用可能性が、もう一つの成長促進要因として作用しています。これとは別に、生体適合性、耐久性、機械的強度、および天然組織との統合を強化し、整形外科用インプラントの成功率と寿命を向上させる高度生体材料のイントロダクションが、市場成長に弾みをつけています。さらに、組織の再生と治癒を促進するために整形外科で使用される天然由来の生分解性材料の利用が、市場の成長に寄与しています。さらに、切開創が小さい、回復が早い、痛みが少ない、入院期間が短いなどの利点から、低侵襲(MI)手術の需要が増加していることも、市場成長にプラスの影響を与えています。その他の要因としては、消費者の支出能力の上昇、広範な研究開発(R&D)活動、ヘルスケアインフラとサービスへの投資の拡大、医療提供者と患者が整形外科用バイオマテリアルと手技を選択することを奨励するさまざまな政府イニシアチブの実施などがあり、市場の成長を支えています。
The global orthopedic biomaterials market size reached US$ 16.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 29.7 Billion by 2028, exhibiting a growth rate (CAGR) of 10.5% during 2022-2028. The rising geriatric population, rapid product innovations, significant growth in the healthcare industry, the implementation of various government initiatives, and extensive research and development (R&D) activities are some of the key factors driving the market.
Orthopedic biomaterials are substances used in orthopedic surgery to replace or repair damaged bone or joint tissues. They are either synthetic or natural and are designed to mimic the properties of bone and joint tissues. Ceramics and bioactive glasses, polymers, calcium phosphate cement, metal, and composites are some of the common types of materials. Orthopedic biomaterials are widely used for joint replacement surgeries, such as hip, knee, and shoulder replacements, fracture fixations, spinal implants, bone grafting, and soft tissue repair. They exhibit high strength, ductility, fracture toughness, hardness, corrosion resistance, formability, and biocompatibility.
The rising geriatric population across the globe prone to the risk of various musculoskeletal disorders, such as osteoarthritis, osteoporosis, and fractures is one of the key factors propelling the market growth. In line with this, the increasing prevalence of orthopedic conditions and injuries, such as sports injuries, degenerative joint diseases, and traumatic fractures, is favoring the market growth. Moreover, the growing awareness about orthopedic disorders and the availability of advanced treatment solutions is acting as another growth-inducing factor. Apart from this, the introduction of advanced biomaterials that offer enhanced biocompatibility, durability, mechanical strength, and integration with natural tissues, improving the success rates and longevity of orthopedic implants, is providing an impetus to the market growth. Additionally, the utilization of biodegradable materials that are derived from natural sources and are used in orthopedics to promote tissue regeneration and healing is contributing to the market growth. Furthermore, the increasing demand for minimally invasive (MI) surgeries due to their advantages, such as smaller incisions, faster recovery, reduced pain, and shorter hospital stays, is positively impacting the market growth. Other factors, including rising expenditure capacities of consumers, extensive research and development (R&D) activities, growing investments in healthcare infrastructure and services, and the implementation of various government initiatives that encourage healthcare providers and patients to opt for orthopedic biomaterials and procedures, are supporting the market growth.
IMARC Group provides an analysis of the key trends in each segment of the global orthopedic biomaterials market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on material type and application.
Ceramics and Bioactive Glasses
Polymers
Calcium Phosphate Cement
Metal
Composites
The report has provided a detailed breakup and analysis of the orthopedic biomaterials market based on the material type. This includes ceramics and bioactive glasses, polymers, calcium phosphate cement, metal, and composites. According to the report, ceramics and bioactive glasses represented the largest segment.
Orthopedic Implants
Joint Replacement/Reconstruction
Orthobiologics
Viscosupplementation
Bio-Resorbable Tissue Fixation
The report has provided a detailed breakup and analysis of the orthopedic biomaterials market based on the application. This includes orthopedic implants, joint replacement/reconstruction, orthobiologics, viscosupplementation, and bio-resorbable tissue fixation. According to the report, orthopedic implants represented the largest segment.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for orthopedic biomaterials. Some of the factors driving the North America orthopedic biomaterials market included the rising geriatric population, various technological advancements, and growing expenditure capacities of consumers.
The report has also provided a comprehensive analysis of the competitive landscape in the global orthopedic biomaterials market. Detailed profiles of all major companies have been provided. Some of the companies covered include Arthrex Inc., Berkeley Advanced Biomaterials, CAM Bioceramics B.V., Collagen Matrix Inc., CoorsTek Inc., Evonik Industries AG (RAG-Stiftung), Exactech Inc., Globus Medical Inc., Invibio Ltd. (Victrex plc), Koninklijke DSM N.V., Medical Devices Business Services Inc., Stryker Corporation, Zimmer Biomet, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.